Marksans Pharma Limited financial statements
Marksans Pharma Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | INR 29.51B | EODHD |
| Net income | INR 4.18B | EODHD |
| Cash and equivalents | INR 6.34B | EODHD |
| Total debt | INR 3.43B | EODHD |
Marksans Pharma Limited financials on 6ix · Marksans Pharma Limited on 6ix